The animal antibiotics market growth can largely be attributed to the rising demand for animal-derived food products, increasing incidence of zoonotic diseases, and the implementation of regulations to prevent the spread of animal diseases. Rising animal healthcare spending and the growing demand for pet insurance are further expected to drive the growth of this market. The untapped emerging markets such as China, India, and Brazil and growth in the overall companion animal population are also expected to offer significant growth opportunities to market players in the coming years.
The global animal antimicrobials and antibiotics market is projected to reach USD 5.6 billion by 2026 from USD 4.7 billion in 2021, at a CAGR of 3.6% from 2021 to 2026.
Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=25161353
Market Segmentation:
Based on products, the global animal antimicrobials and antibiotics market is segmented into tetracyclines, penicillins, sulfonamides, macrolides, aminoglycosides, lincosamides, fluoroquinolones, cephalosporins, and other antimicrobial and antibiotic products. In 2020, the tetracyclines segment accounted for 48.9% of the global animal antimicrobials market. Tetracyclines exhibit advantages such as the highest potency against pathogenic microorganisms, are well-absorbed, show low toxicity, and are relatively inexpensive compared to other animal antimicrobial and antibiotic products. These advantages contribute to the large share of this product segment. The fluoroquinolones segment is expected to grow at the highest CAGR of 8.0% during the forecast period. Advantages such as higher efficacy at low concentrations, quick penetration through tissues, and the availability of variations in the route of administration result in the higher adoption of fluoroquinolones among end users.
Based on the mode of delivery, the global animal antimicrobials and antibiotics market is segmented into premixes, oral powders, oral solutions, injections, and other modes of delivery. In 2020, the premixes segment accounted for the largest share of 46.3% of the global animal antibiotics market. The large share of this segment can be attributed to the advantages of premixes, such as simplified mode of administration and lower instability and hygroscopicity of formulations. The injections segment is expected to witness the highest CAGR of 4.9% during the forecast period. Advantages such as immediate delivery of drugs and rapid onset of drug effects are expected to drive growth in this market.
Based on animal type, the global animal antimicrobials and antibiotics market is categorized into food-producing animals and companion animals. In 2020, the food-producing animals segment accounted for the largest share of around 73.4%. This segment is also expected to register the highest CAGR of 3.9% during the forecast period. The large share of this segment is mainly due to the rising demand for animal-derived food products, increase in animal healthcare expenditure, and greater concerns about zoonotic diseases.
Regional Analysis:
The animal antimicrobials and antibiotics market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of 30.3% of the global animal antimicrobials market. The large share of this region is mainly due to the increase in the region's animal population, rising demand for animal-derived food products, growth in pet insurance, and rising animal health expenditure compared to other regions.
The Asia Pacific region is projected to grow at the highest CAGR of 5.4% during the forecast period. Factors such as the rapidly increasing animal population and rising demand for animal-derived food products are driving the growth of this market in the APAC.
Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=25161353
Top Key Players:
Some of the prominent players in the animal antimicrobials and antibiotics market are Boehringer Ingelheim (Germany), Zoetis Inc. (US), Elanco Animal Health (US), Merck & Co. Inc (US), Phibro Animal Health (US), Virbac (France), Vetoquinol S.A. (France), Ceva Santé Animale (France), Dechra Pharmaceuticals Plc (UK), Kyoritsu Seiyaku (Japan), Tianjin Ringpu (China), HIPRA (Spain), Zydus Animal Health (US), China Animal Husbandry (China), and Inovet (Belgium).
Market Research Future (MRFR) has published a research report about global animal antibiotics and antimicrobials market that estimates rise for this market with 4.50% CAGR (Compound Annual Growth Rate) for this market between 2017 and 2023.
Evaluating market size and calculating the revenue, this report covers and observes the competitive developments of market players that include joint ventures, new product developments, mergers and acquisitions, research and developments (R & D), and strategic alliances.
However, growing resistance to anti microbials and antibiotics opportunities can restrain the market growth.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/6680Segmentation:The global animal antibiotics and antimicrobials market has been segmented on the basis of delivery type, end user type, product type, and region.
Based on delivery type, this market has been segmented into injections, oral powder, oral solutions, premixes, and others.
Segmentation based on product type segments the market into aminocoumarins, aminoglycosides, bicyclomycin, cephalosporins, fluoroquinolones, fusidic acid, macrolides, penicillin, phenicols, sulfonamides, and tetracyclines.Regional Analysis:The regional segmentation of the global animal antibiotics and antimicrobials market segments the market into continent-based regional markets known as The Americas (North America & South America), Europe, Asia Pacific, and the Middle East & Africa (MEA).The Americas always have the potential to be the largest regional market.
North America anyways alone is capable of emerging as the largest market due to its strong economies are known as the United States of America (USA) and Canada.
Global Animal Antibiotics and Antimicrobials Market Research Report Information by Delivery Type (Injections, Oral powder, Oral solutions, Premixes, Others), Product Type (Aminocoumarins, Aminoglycosides, Bicyclomycin, etc) and Region - Forecast To 2027.Overview:Animal antibiotics and antimicrobials are needed to cure bacterial infections.
Animal antibiotics and antimicrobials are used to treat the husbandry of livestock when they are found ill, or any one of them is suffering in a herd to prevent further spreading of the disease.
These are also used to increase production.The global animal antibiotics and antimicrobials market is expected to benefit from factors such as its contribution to the food & beverage industry, healthcare sector, pet care sector, and others.
In human healthcare, the segment can contribute impressively by creating antibacterial that would increase resistance against any kind of bacterial infection.
The food producing animals segment is substantially big and invites a lot of investments on which it can thrive later.Based on the product type, the animal antibiotics and antimicrobials market can be segmented into aminoglycosides, aminocoumarins, cephalosporins, bicyclomycin, fluoroquinolones, macrolides, penicillin, sulfonamides, phenicols, fusidic acid, and tetracyclines.Regional Analysis:MRFR in their latest report on the regional segmentation of the global animal antibiotics and antimicrobials market includes the Americas (North America & South America), Europe, Asia Pacific, and the Middle East & Africa (MEA) as a part of their intent to study it based on continent-wise production.The Americas, due to advanced medical facilities, research facilities, and investments on the animal-based products is holding immense potential.
Mostly, it is Germany, France, Spain, Italy, and the United Kingdom (UK), who are contributing considerably to the progress of the regional market.The APAC is mostly untapped, but its potential is immense.
